财中社2月11日电第一医药(600833)发布公告,2025年度日常经营性关联交易预计的情况。根据公告,公司预计在2025年度与百联集团及国药控股发生日常经营性关联交易,预计交易金额合计约为6085万元。公告中提到,关联交易定价公允,且不对公司的财务状况和经营成果产生不利影响,公司的独立性也不会受到影响。在2024年度,公司与上述关联方的实际发生金额为6593万元,显示出与预计金额之间的差异,主要...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.